HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A double-blind comparison of the effects of haloperidol and cis(Z)-clopenthixol in senile dementia.

Abstract
The therapeutic effects in senile dementia of haloperidol and cis(Z)-clopenthixol were compared in a double-blind, double-dummy clinical 8-week study in 47 demented patients after wash-out periods of 3 weeks or less. Forty patients, most of whom received 0.5 mg haloperidol or 5 mg cis(Z)-clopenthixol, completed the study in which assessments with the geriatric rating scales of Gottfries-Cronholm and Crichton in addition to CGI were done at weeks--3, 0, 1, 2, 4, and 8. With the Gottfries-Cronholm Scale few significant changes from week 0 were seen in the two groups of patients. Significant deteriorations at weeks 1 and 8 in the haloperidol group were, however, registered. The only significant difference between the two groups of patients regarded motor activity which was most positively influenced by cis(Z)-clopenthixol. Accordingly, most results suggesting a difference between the two test drugs were in the favour of cis(Z)-clopenthixol. With the Crichton and the CGi scales changes in the over-all impression of the patients were very few. Side effects were mild and transient.
AuthorsK G Götestam, S Ljunghall, B Olsson
JournalActa psychiatrica Scandinavica. Supplementum (Acta Psychiatr Scand Suppl) Vol. 294 Pg. 46-53 ( 1981) ISSN: 0065-1591 [Print] Denmark
PMID7041519 (Publication Type: Clinical Trial, Comparative Study, Journal Article)
Chemical References
  • Thioxanthenes
  • Clopenthixol
  • Haloperidol
Topics
  • Aged
  • Clinical Trials as Topic
  • Clopenthixol (therapeutic use)
  • Dementia (drug therapy)
  • Double-Blind Method
  • Female
  • Haloperidol (therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • Psychiatric Status Rating Scales
  • Stereoisomerism
  • Thioxanthenes (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: